What is Odyssey Therapeutics worth?
$638.2Mlast known valuation
Odyssey Therapeutics last raised $214.0M in its Later Stage VC (Jun 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 32 names
- ·Watchlist + deal alerts for Odyssey Therapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Later Stage VC | $214.0M | ▮ | ▮ |
| Oct 2023 | Later Stage VC | $117.2M | ▮ | ▮ |
| Oct 2022 | Early Stage VC (Series B) | $168.0M | ▮ | ▮ |
| Aug 2021 | Later Stage VC | $91.6M | ▮ | ▮ |
How Odyssey Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Odyssey Therapeutics, we compose those signals into the PA Mark — a weighted composite of 1 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is Odyssey Therapeutics worth?
- Odyssey Therapeutics's implied valuation is $638.2M, based on the PA Mark composite price of about $17 per share as of Sep 2026.
- How much has Odyssey Therapeutics raised?
- Odyssey Therapeutics has raised $716.2M in total funding across 4 recorded rounds.
- When did Odyssey Therapeutics last raise?
- Odyssey Therapeutics last raised in Jun 2025 (Later Stage VC), raising $214.0M.